| Mrs Ashley Blackmon, NP | |
|
1968 Peachtree Rd Nw, Atlanta, GA 30309-1281 | |
| (404) 367-3014 | |
| Not Available |
| Full Name | Mrs Ashley Blackmon |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1968 Peachtree Rd Nw, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306107685 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastside Medical Center | Snellville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Cardiology Of Atlanta, Llc | 0345321691 | 402 |
News Archive
A $9.5 million, five-year grant from the National Cancer Institute (NCI) will fund an intensive multidisciplinary research effort that seeks to better understand how cancer cells reach an aggressive state and begin to damage surrounding tissue.
In Queensland, Australia cancer researchers have given new hope to women who enjoy the occasional glass of wine. Their study showed the risk of developing ovarian cancer was dramatically reduced in women who drank at least one standard glass of wine a day.
Medtronic, Inc.today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted unanimously in favor of approval with conditions of the Revo MRI™ SureScan™ pacing system designed as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions.
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
The development of Alzheimer's disease and the way it spreads throughout the brain will be the focus of a pioneering study conducted at Aston University (UK).
› Verified 3 days ago
| Entity Name | Piedmont Cardiology Of Atlanta, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275729691 PECOS PAC ID: 0345321691 Enrollment ID: O20080114000153 |
News Archive
A $9.5 million, five-year grant from the National Cancer Institute (NCI) will fund an intensive multidisciplinary research effort that seeks to better understand how cancer cells reach an aggressive state and begin to damage surrounding tissue.
In Queensland, Australia cancer researchers have given new hope to women who enjoy the occasional glass of wine. Their study showed the risk of developing ovarian cancer was dramatically reduced in women who drank at least one standard glass of wine a day.
Medtronic, Inc.today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted unanimously in favor of approval with conditions of the Revo MRI™ SureScan™ pacing system designed as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions.
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
The development of Alzheimer's disease and the way it spreads throughout the brain will be the focus of a pioneering study conducted at Aston University (UK).
› Verified 3 days ago
| Entity Name | Ahmed Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831579812 PECOS PAC ID: 6305159930 Enrollment ID: O20150724011591 |
News Archive
A $9.5 million, five-year grant from the National Cancer Institute (NCI) will fund an intensive multidisciplinary research effort that seeks to better understand how cancer cells reach an aggressive state and begin to damage surrounding tissue.
In Queensland, Australia cancer researchers have given new hope to women who enjoy the occasional glass of wine. Their study showed the risk of developing ovarian cancer was dramatically reduced in women who drank at least one standard glass of wine a day.
Medtronic, Inc.today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted unanimously in favor of approval with conditions of the Revo MRI™ SureScan™ pacing system designed as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions.
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
The development of Alzheimer's disease and the way it spreads throughout the brain will be the focus of a pioneering study conducted at Aston University (UK).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ashley Blackmon, NP 95 Collier Rd Nw, Suites 4055, 4075, And 4085, Atlanta, GA 30309-1796 Ph: (404) 834-7534 | Mrs Ashley Blackmon, NP 1968 Peachtree Rd Nw, Atlanta, GA 30309-1281 Ph: (404) 367-3014 |
News Archive
A $9.5 million, five-year grant from the National Cancer Institute (NCI) will fund an intensive multidisciplinary research effort that seeks to better understand how cancer cells reach an aggressive state and begin to damage surrounding tissue.
In Queensland, Australia cancer researchers have given new hope to women who enjoy the occasional glass of wine. Their study showed the risk of developing ovarian cancer was dramatically reduced in women who drank at least one standard glass of wine a day.
Medtronic, Inc.today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted unanimously in favor of approval with conditions of the Revo MRI™ SureScan™ pacing system designed as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions.
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.
The development of Alzheimer's disease and the way it spreads throughout the brain will be the focus of a pioneering study conducted at Aston University (UK).
› Verified 3 days ago